(S)-tert-Butyl (1-cyclohexylpyrrolidin-3-yl)carbamate

Catalog No.: 
ACDKAV451
CAS No.: 
178688-10-3
Molecular Formula: 
C15H28N2O2
Molecular Weight: 
268.40
(S)-tert-Butyl (1-cyclohexylpyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$299.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl (1-cyclohexylpyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (S)-(1-cyclohexylpyrrolidin-3-yl)carbamate
MDL No.MFCD17014224
Molecular FormulaC15H28N2O2
Molecular Weight268.40
SMILESO=C(OC(C)(C)C)N[C@@H]1CN(C2CCCCC2)CC1
InChI KeyOWXMMRQDSKAHST-LBPRGKRZSA-N
Synonym(S)-tert-Butyl 1-cyclohexylpyrrolidin-3-ylcarbamate;Carbamic acid, (1-cyclohexyl-3-pyrrolidinyl)-, 1,1-dimethylethyl ester, (S)- (9CI)
CAS No.178688-10-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDKAV451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIXG127 route compound structure diagram
    ACLIXG127122536-76-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKAV451 route product structure diagram
    ACDKAV451178688-10-3
Inquiry

2. ACDKAV451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDKAV451 route product structure diagram
    ACDKAV451178688-10-3
Inquiry

3. ACDKAV451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDKAV451 route product structure diagram
    ACDKAV451178688-10-3
Inquiry

Comments (0)